Signal: Project NextGen continues with $500m funding for vaccine research
US Covid-19 research initiative Project NextGen is continuing apace, announcing on Friday (13 October) that the Department for Health and…
US Covid-19 research initiative Project NextGen is continuing apace, announcing on Friday (13 October) that the Department for Health and…
eFFECTOR Therapeutics has reported positive top-line data from its Phase Ib clinical trial of zotatifin to treat Covid-19. The potent…
GeoVax Labs and decentralised trial global organisation EmVenio Research have announced a partnership for the deployment of a mobile clinical…
GreenLight Biosciences has received the Rwanda Food and Drugs Authority (Rwanda FDA) approval for a Phase I/II clinical trial of…
Dyadic International has initiated subject dosing in its Phase I clinical trial of the Covid-19 recombinant protein receptor binding domain…
Tevogen Bio has reported positive topline data from a clinical trial of off-the-shelf, allogeneic cytotoxic CD8+ T cell therapy TVGN…
Ascletis Pharma has dosed the first cohort’s four healthy participants in a Phase I clinical trial of its oral therapy…
American CryoStem is set to proceed with a Phase I clinical trial of its ATCELL therapy to treat Long Covid/PASC,…
Meijisubsidiary Meiji Seika Pharma has commenced a Phase III clinical trial of a messenger ribonucleic acid (mRNA) vaccine, ARCT-154, for…
Ascletis Pharma has reported positive topline data from the Phase I multiple ascending dose (MAD) clinical trial of its prodrug, ASC10, in…